Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06133504
Other study ID # SECEC-2023-129
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 2024
Est. completion date June 2025

Study information

Verified date November 2023
Source Fundación Santa Fe de Bogota
Contact Jorge Alvarado, MD
Phone 3017858459
Email jialvarados@unal.edu.co
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess the association between early multimodal therapy and the duration of invasive mechanical ventilation in the Intensive Care Unit at Fundación Santa Fe de Bogotá.


Description:

This study compares the impact of early multimodal therapy on mechanical ventilation duration in ICU patients. It is an open-label, randomized controlled clinical trial. Patients will be assigned to either early multimodal therapy or standard therapy (control) in a 1:1 ratio. Blinding is not possible due to the study design. The analysis will follow an intention-to-treat approach. The hypothesis is that early multimodal therapy reduces mechanical ventilation duration


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 74
Est. completion date June 2025
Est. primary completion date June 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: The inclusion criteria are as follows: Patients hospitalized in the adult intensive care unit of the Fundación Santa Fe de Bogotá. Requirement of invasive mechanical ventilation through an endotracheal tube for a period exceeding 72 hours with an expected continuation of at least 24 hours. Barthel Index equal to or greater than 70 Exclusion Criteria: Exclusion criteria: - Patients requiring invasive mechanical ventilation through a tracheostomy tube or nasotracheal tube. - Patients who have undergone any type of head and neck surgery. - Cardiac arrest. - Airway burn. - Burns with an extent greater than 50% of the body surface area. - Patients with chronic obstructive pulmonary disease. - Patients referred from another institution. - Demyelinating or neuromuscular junction diseases. - Patients requiring neuromuscular blockade. - Patients with a life expectancy of less than 180 days. - Patients deemed by medical criteria not to benefit from multimodal treatment. - Patients not entering the ICU for the first time. - Patients participating in other clinical rehabilitation trials

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Early Multimodal Therapy
Early multimodal therapy is defined as the collection of therapeutic maneuvers performed by the physiotherapy, speech therapy, respiratory therapy, and occupational therapy team at the time of study inclusion.
Late Multimodal Therapy
Late multimodal therapy is characterized by the same set of maneuvers carried out by the same disciplinary team, but it is initiated once indicated by the attending physician.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Fundación Santa Fe de Bogota

Outcome

Type Measure Description Time frame Safety issue
Primary Time (days) from intubation to extubation. Days of mechanical ventilation duration 28 days
Secondary Ventilator-free days until day 28 28 minus the days of mechanical ventilation 28 days
Secondary Delirium days until day 28 In order for a patient to be considered to have delirium according to the CAM-ICU, the first criterion (acute change in mental status) must be present, along with at least one of the other three criteria (inability to maintain sustained attention, disorganized thinking, or fluctuating levels of consciousness). 28 days
Secondary Delirium-free days until day 28 28 minus days with presence of delirium 28 days
Secondary Sedation days until day 28. Sedation days until day 28. 28 days
Secondary Sedation-free days until day 28 28 days minus days of sedation 28 days
Secondary Barthel Index at hospital discharge The Barthel Index is a scale used to measure the degree of functional independence in activities of daily living (ADLs) for an individual. The score is 0 if the patient deceases. 90 days
Secondary Hospitalization days Hospitalization days 90 days
Secondary ICU length of stay ICU length of stay 28 days
Secondary Mortality from any cause up to 90 days Mortality from any cause up to 90 days 90 days
Secondary Functional independence status measured by ADLs at hospital discharge Activities of Daily Living (ADLs), each variable scores one point: bathing, dressing, eating, grooming, transferring from bed to chair, and using the bathroom 90 days
Secondary Functional independence status measured by ADLs at ICU discharge Activities of Daily Living (ADLs), each variable scores one point: bathing, dressing, eating, grooming, transferring from bed to chair, and using the bathroom 28 days
Secondary Muscle strength measured using the Medical Research Council (MRC) scale Muscle strength assessment in critical care patients using the Medical Research Council (MRC) scale:
5: Normal - Full range of motion against total resistance 4+: Good (+) - Full range of motion against gravity and strong resistance 4: Good (-) - Full range of motion against gravity and minimal resistance 3+: Fair (+) - Full range of motion against gravity only 3: Fair (-) - Partial range of motion against gravity 2: Poor - Movement with gravity eliminated
1: Minimal - Visible muscle contraction without movement 0: Absent - Total paralysis
28 days
Secondary Swallowing difficulty at 72 hours. Presence of dysphagia at 72 hours after extubation 28 days
Secondary Time until the initiation of oral intake Time to initiate oral intake after extubation: 1) 12-24 hours, 2) > 24 hours 28 days
Secondary Development of healthcare-associated pneumonia Pneumonia associated with invasive mechanical ventilation. Yes or no. 28 days
Secondary Maximum mobility measured by JH-HLM (Johns Hopkins Highest Level of Mobility) scale Mobility assessment using the JH-HLM (Johns Hopkins Highest Level of Mobility) scale:
8: Walks more than 250 feet. 7: Walks more than 25 feet. 6: Walks more than 10 steps. 5: Stands for more than one minute. 4: Can move to the chair. 3: Can sit on the edge of the bed. 2: Can turn in bed.
1: Can only lie down. Score is 0 if the patient deceases.
28 days
Secondary Grip strength Grip strength of the dominant hand within 24 hours post-extubation. Kilograms. Score is 0 if the patient deceases 28 days
Secondary Extubation failure Inability to breathe spontaneously in the first 48 hours after removal of artificial airway, and the patient is unable to maintain a patent airway 28 days
Secondary Need for non-invasive mechanical ventilation Need for non-invasive mechanical ventilation: Yes or No 28 days
Secondary Cognitive function measured using the Montreal Cognitive Assessment (MOCA). The variable is the cognitive function, assessed using the Montreal Cognitive Assessment (MOCA). This tool measures various cognitive domains, providing insight into an individual's cognitive abilities and identifying potential cognitive impairment 90 days
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT03671447 - Enhanced Recovery After Intensive Care (ERIC) N/A
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Completed NCT04239209 - Effect of Intensivist Communication on Surrogate Prognosis Interpretation N/A
Completed NCT05531305 - Longitudinal Changes in Muscle Mass After Intensive Care N/A
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT02916004 - The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients. N/A
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04479254 - The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study) N/A
Recruiting NCT04475666 - Replacing Protein Via Enteral Nutrition in Critically Ill Patients N/A
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Withdrawn NCT04043091 - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Completed NCT03048487 - Protein Consumption in Critically Ill Patients
Completed NCT02899208 - Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients? N/A
Recruiting NCT02163109 - Oxygen Consumption in Critical Illness